BRAF/MEK inhibitor therapycoronary artery bypass graftingmetastatic BRAF V600E mutant diseasemetastatic melanoma
… liver and bone. He was unable to tolerate 2 months in total of BRAF/MEK inhibitor therapy because of multiple toxicities and subsequently developed progr…